International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
The DOI matches its Crossref record; 321 of the 321 references it cites were found in a registry or an index.
Abstract
Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A Task Force, supported by the European Respiratory Society and American Thoracic Society, reviewed the definition and provided recommendations and guidelines on the evaluation and treatment of severe asthma in children and adults. A literature review was performed, followed by discussion by an expert committee according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach for development of specific clinical recommendations. When the diagnosis of asthma is confirmed and comorbidities addressed, severe asthma is defined as asthma that requires treatment with high dose inhaled corticosteroids plus a second controller and/or systemic corticosteroids to prevent it from becoming “uncontrolled” or that remains “uncontrolled” despite this therapy. Severe asthma is a heterogeneous condition consisting of phenotypes such as eosinophilic asthma. Specific recommendations on the use of sputum eosinophil count and exhaled nitric oxide to guide therapy, as well as treatment with anti-IgE antibody, methotrexate, macrolide antibiotics, antifungal agents and bronchial thermoplasty are provided. Coordinated research efforts for improved phenotyping will provide safe and effective biomarker-driven approaches to severe asthma therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when “severe asthma” was defined using ERS/ATS (35) or WHO (41) criteria, only a small number of children were classified as having severe asthma, suggesting that we need to look beyond the amount of medication and disease control when defining severe disease (46).”
From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [35]
Citations
Cites
Items 201–321 of 321
Function and Regulation of SPLUNC1 Protein in Mycoplasma Infection and Allergic Inflammation
Chu, H. W., Thaikoottathil, J., Rino, J. G., Zhang, G., Wu, Q., Moss, T., Refaeli, Y., Bowler, R. P., Wenzel, S. E., Chen, Z., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3995 · Cited by 143
Self-citationIL4Rα Mutations Are Associated with Asthma Exacerbations and Mast Cell/IgE Expression
Wenzel, S. E., Balzar, S., Ampleford, E., Hawkins, G. A., Busse, W. W., Calhoun, W. J., Castro, M., Chung, K. F., Erzurum, S., Gaston, B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-909oc · Cited by 142 · cited 2×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundSelf-citationEffects of Terbutaline and Budesonide on Sputum Cells and Bronchial Hyperresponsiveness In Asthma
Aldridge, R. E., Hancox, R. J., Taylor, D. R., Cowan, J. O., WINN, M. C., Frampton, C. M., & Town, G. I. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9906052 · Cited by 140
Jatakanon, A., Lalloo, U., Lim, S., Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.3.234 · Cited by 140
Self-citationA study of a multi-level intervention to improve non-adherence in difficult to control asthma
Gamble, J., Stevenson, M., & Heaney, L. G. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.03.019 · Cited by 139 · cited 3×
“If non-adherence is present, clinicians should empower patients to make informed choices about their medicines and develop individualized interventions to manage non-adherence [170].”
BackgroundSpecificity of basement membrane thickening in severe asthma
BOURDIN, A. A., Neveu, D., Vachier, I., Paganin, F., Godard, P., & Chanez, P. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.055 · Cited by 138 · cited 1×
“Subepithelial thickening of the bronchial reticular layer is an early feature of severe asthma in children, and appears to be a characteristic of the eosinophilic phenotype [28, 123, 124].”
BackgroundSelf-citationAddition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
Chróinín, M. N., Lasserson, T. J., Greenstone, I., & Ducharme, F. M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007949 · Cited by 138
Importance of hedgehog interacting protein and other lung function genes in asthma
Li, X., Howard, T. D., Moore, W. C., Ampleford, E. J., Li, H., Busse, W. W., Calhoun, W. J., Castro, M., Chung, K. F., Erzurum, S. C., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.056 · Cited by 137 · cited 1×
“Finally, there is evidence that genetic variation in a number of genes may interact and influence lung function, asthma susceptibility and severity [50].”
BackgroundSelf-citationAirway smooth muscle remodeling is a dynamic process in severe long-standing asthma
Hassan, M., Jo, T., Risse, P., Tolloczko, B., Lemière, C., Olivenstein, R., Hamid, Q. A., & Martin, J. G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.031 · Cited by 136 · cited 1×
“Second, autopsy and biopsy studies have linked an increased amount of airway smooth muscle to asthma severity, airflow obstruction and bronchial hyperresponsiveness [82, 117-120].”
BackgroundSelf-citationGreniér, P., Mourey-Gerosa, I., Benali, K., Brauner, M., Leung, A. N. C., Lenoir, S., Cordeau, M., & Mazoyer, B. M. (1996) · European Radiology · doi:10.1007/bf00181147 · Cited by 135 · cited 1×
“Eight studies reported the results of chest HRCT in patients with asthma [160-164].”
Humbert, M., De Blay, F., Garcia, G., Prud’homme, A., Leroyer, C., Magnan, A., Tunon‐de‐Lara, J. ‐., Pison, C., Aubier, M., Charpin, D., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02122.x · Cited by 135 · cited 2×
“020) Better response in those with higher IL-13 levels in sputum Humbert et al, 2009 [324] Severe, CSdependent/44 R, db, pc, p Masitinib (3, 4.”
BackgroundSelf-citationStrunk, R. C., Bacharier, L. B., Phillips, B. R., Szefler, S. J., Zeiger, R. S., Chinchilli, V. M., Martinez, F. D., Lemanske, R. F., Taussig, L. M., Mauger, D. T., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.028 · Cited by 134 · cited 6×
“Two studies included children [300, 306] and two included adults [301, 305].”
BackgroundInfluentialCox, L., Lieberman, P. L., Wallace, D. V., Simons, F. E. R., Finegold, I., Platts‐Mills, T. A. E., & Schwartz, L. B. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.010 · Cited by 131 · cited 1×
“anaphylaxis [285, 286].”
Exhaled nitric oxide in the management of childhood asthma: A prospective 6‐months study
Fritsch, M., Uxa, S., Horak, F., Putschoegl, B., Dehlink, E., Szepfalusi, Z., & Frischer, T. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20455 · Cited by 130 · cited 1×
“Four studies explicitly included children [47, 257-259], one included adolescents [260], and three studies enrolled”
BackgroundExhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
van Veen, I. H., Brinke, A. T., Sterk, P. J., Sont, J. K., Gauw, S. A., Rabe, K. F., & Bel, E. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00135907 · Cited by 130
Self-citationAirway remodeling is correlated with obstruction in children with severe asthma
Tillie‐Leblond, I., Jacques de, B. L. I. C., Jaubert, F., Wallaert, B., Scheinmann, P., & Gosset, P. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01656.x · Cited by 127 · cited 1×
“Structural alterations can affect airway mechanics, while structural cells can also contribute to inflammatory processes through release of cytokines, chemokines, growth factors and extracellular matrix elements [114].”
BackgroundHaselkorn, T., Zeiger, R. S., Chipps, B. E., Mink, D. R., Szefler, S. J., Simons, F. E. R., Massanari, M. J., & Fish, J. E. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.006 · Cited by 127 · cited 2×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundThe Presence of Rhinovirus in Lower Airways of Patients with Bronchial Asthma
Woś, M., Sanak, M., Soja, J., Olechnowicz, H., Busse, W. W., & Szczeklik, A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-973oc · Cited by 126 · cited 1×
“relation to asthma severity has rarely been addressed [88-90].”
BackgroundFibrocyte localization to the airway smooth muscle is a feature of asthma
Saunders, R. M., Siddiqui, S., Kaur, D., Doe, C., Sutcliffe, A., Hollins, F., Bradding, P. H., Wardlaw, A. J., & Brightling, C. E. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.048 · Cited by 126 · cited 1×
“Finally, fibrocytes, which can differentiate into myofibroblasts, are increased in blood and in smooth muscle bundles in asthmatics with fixed airways obstruction and/or severe asthma [121, 122].”
BackgroundSelf-citationDetrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity
Comhair, S. A. A., Gaston, B. M., Ricci, K. S., Hammel, J., Dweik, R. A., Teague, W. G., Meyers, D., Ampleford, E. J., Bleecker, E. R., Busse, W. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018574 · Cited by 125 · cited 2×
“Environmental tobacco smoke exposure is also associated with adverse asthma outcomes in children and adults [40].”
BackgroundSelf-citationUse of sputum eosinophil counts to guide management in children with severe asthma
Fleming, L., Wilson, N., Regamey, N., & Bush, A. (2012) · Thorax · doi:10.1136/thx.2010.156836 · Cited by 123 · cited 1×
“by sputum analysis in adults, this approach has been less informative in children in which a stable predominant sputum inflammatory phenotype has not yet been identified [188].”
Self-citationSpears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G., Adcock, I. M., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00158208 · Cited by 122 · cited 1×
“In an exploratory study of smoking asthmatics with CS insensitivity, theophylline with low dose ICS improved peak expiratory flow rates and asthma control [238], raising the possibility that theophylline could improve CS insensitivity in some people.”
BackgroundSelf-citationAllergic Airway Inflammation Inhibits Pulmonary Antibacterial Host Defense
Beisswenger, C., Kandler, K., Hess, C., Garn, H., Felgentreff, K., Wegmann, M., Renz, H., Vogelmeier, C., & Bals, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1833 · Cited by 122 · cited 1×
“In addition, the antimicrobial activity of airway epithelial cells and their production of β-defensins is reduced when these cells are exposed to T-helper type 2 (Th2) cytokines, while allergic inflammation leads to a reduction in cathelicidin antimicrobial peptide [98, 99].”
BackgroundLai, C. K. W., Twentyman, O. P., & Holgate, S. T. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.4.917 · Cited by 118
PIACENTINI, G. L., Peroni, D. G., Bodini, A., Pigozzi, R., Costella, S., Loiacono, A., & Boner, A. L. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap.2007.28.2958 · Cited by 116 · cited 1×
“We identified six additional randomized trials of macrolide antibiotics in patients with asthma [302-307] that have been published since the search for the review by Richeldi and colleagues”
BackgroundConsistency of sputum eosinophilia in difficult-to-treat asthma: A 5-year follow-up study
van Veen, I. H., Brinke, A. T., Gauw, S. A., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.029 · Cited by 114
Self-citationPetsky, H., Li, A., & Chang, A. B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005603.pub3 · Cited by 114
Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma
Nguyen, L. T., Lim, S., Oates, T., & Chung, K. F. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.06.007 · Cited by 113
Self-citationHigh-resolution CT Features of Severe Asthma and Bronchiolitis Obliterans
Jensen, S. P., Lynch, D. A., Brown, K. M., Wenzel, S. E., & Newell, J. D. (2002) · Clinical Radiology · doi:10.1053/crad.2002.1104 · Cited by 112 · cited 2×
“Jensen and colleagues reviewed charts of 30 patients with severe asthma (an HRCT was done prior to the study as part of the patients’ evaluation for unreported reasons) [159].”
BackgroundSelf-citationGibson, P. G. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03226.x · Cited by 111
Self-citationRand, I. A. D., Barber, P. V., Goldring, J. J. P., Lewis, R. A., Mandal, S., Munavvar, M., Rintoul, R. C., Shah, P. L., Singh, S., Slade, M. G., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-201052 · Cited by 110 · cited 3×
“British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults state that the place of bronchial thermoplasty “in the treatment of asthma remains to be established and we recommend that treatment should be limited to a few specialist centres in carefully selected patients”…”
BackgroundInfluentialOborne, J., Mortimer, K., Hubbard, R. B., Tattersfield, A. E., & Harrison, T. W. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0616oc · Cited by 108 · cited 1×
“However, this is often not practical in severe asthma since these patients are already maintained on high doses of ICS [211, 212].”
BackgroundCorticosteroid responsiveness and clinical characteristics in childhood difficult asthma
Bossley, C. J., Saglani, S., Kavanagh, C., Payne, D. N. R., Wilson, N., Tsartsali, L., Rosenthal, M., Balfour-Lynn, I. M., Nicholson, A. G., & Bush, A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00186508 · Cited by 108 · cited 2×
“The association between allergy and asthma severity is stronger in children [145, 171].”
BackgroundSelf-citation75 deaths in asthmatics prescribed home nebulisers.
Sears, M. R., Rea, H. H., Fenwick, J., Gillies, A. J., Holst, P. E., O'Donnell, T. V., & Rothwell, R. (1987) · BMJ · doi:10.1136/bmj.294.6570.477 · Cited by 105 · cited 1×
“The routine use of nebulizers is discouraged owing to their relative inefficiency in drug delivery and because their use has been associated with deaths in severe asthma, thought to result from reliance on their use and delays in seeking help during evolving exacerbations [235].”
Kowalski, M. L., Cieślak, M., Pérez-Novo, C. A., Makowska, J. S., & Bachert, C. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02379.x · Cited by 104 · cited 1×
“fixed airflow limitation has been associated with positive serology for intracellular pathogens, such as Chlamydia pneumoniae [34, 91, 92].”
BackgroundMethotrexate as a steroid sparing agent for asthma in adults
Davies, H. R. H. R., Olson, L. G., & Gibson, P. G. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000391 · Cited by 102
Self-citationKamada, A. K., Hill, M. R., Iklé, D. N., Brenner, A. M., & Szefler, S. J. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90345-g · Cited by 101
Park, J., Hong, Y. K., Kim, C. W., Kim, D. K., Choe, K. O., & Hong, C.-S. (1997) · PubMed · Cited by 100
Prevalence of psychiatric morbidity in a difficult asthma population: Relationship to asthma outcome
Heaney, L. G., Conway, E., Kelly, C., & Gamble, J. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.02.013 · Cited by 99 · cited 2×
“Page 35 of 112 these conditions are under-diagnosed, so appropriate psychiatric evaluation and referral to a specialist is recommended [180].”
BackgroundBacteria in sputum of stable severe asthma and increased airway wall thickness
Zhang, Q., Illing, R., Hui, C. K., Downey, K., Carr, D., Stearn, M., Alshafi, K., Menzies-Gow, A., Zhong, N., & Fan Chung, K. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-35 · Cited by 99 · cited 1×
“sputum samples of severe asthmatic patients without evidence of bronchiectasis and from those with a long duration of asthma and exacerbations in the past year [94].”
BackgroundSelf-citationThe IL6R variation Asp358Ala is a potential modifier of lung function in subjects with asthma
Hawkins, G. A., Robinson, M. B., Hastie, A. T., Li, X., Li, H., Moore, W. C., Howard, T. D., Busse, W. W., Erzurum, S. C., Wenzel, S. E., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.018 · Cited by 98 · cited 1×
“Another recent paper showed that variation in IL6- receptor (IL6-R) associated with lower lung function and more severe asthma subphenotypes suggesting another therapeutic target [49].”
BackgroundSelf-citationGodard, P., Adelroth, E. C., Ayres, J. G., Barnes, N., Barnes, P. J., Bel, E. H., Burney, P., Chanez, P., Connett, G. J., Corrigan, C. J., et al. (1999) · Cited by 97
Self-citationNelson, H. S., Hamilos, D. L., Corsello, P., Levesque, N. V., Buchmeier, A. D., & Bucher‐Bartelson, B. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.398 · Cited by 97
Chlumský, J., Střı́ž, I., Teřl, M., & Vondráček, J. (2006) · Journal of International Medical Research · doi:10.1177/147323000603400202 · Cited by 97 · cited 3×
“This review included three randomized controlled trials in adults [182, 249, 250].”
BackgroundMethodBisaccioni, C., Aun, M. V., Cajuela, E., Kalil, J. E., Agondi, R. C., & Junior, P. F. G.-B. (2009) · Clinics · doi:10.1590/s1807-59322009000800010 · Cited by 97 · cited 1×
“selection criteria were reported in the article or not) [126, 156-159].”
BackgroundFluticasone at different doses for chronic asthma in adults and children
Adams, N. P., Bestall, J. C., Jones, P., Lasserson, T. J., Griffiths, B., & Cates, C. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003534.pub3 · Cited by 96 · cited 2×
“However, there is individual variation in the dose-therapeutic efficacy of ICS and some evidence that higher ICS doses may be more efficacious in severe asthma (including a systemic CS-sparing effect) [209] [210].”
BackgroundPsychological interventions for adults with asthma
Yorke, J., Fleming, S. L., & Shuldham, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002982.pub3 · Cited by 95
A Comparison of Obese and Nonobese People With Asthma
Pakhale, S. S., Doucette, S. P., Vandemheen, K. L., Boulet, L., McIvor, A., FitzGerald, J. M., Hernandez, P., Lemière, C., Sharma, S., Field, S. K., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-2491 · Cited by 95
Self-citationHojo, M., Iikura, M., HIRANO, S., Sugiyama, H., Kobayashi, N., & Kudo, K. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02076.x · Cited by 95 · cited 1×
“comorbid/masquerading condition was done prior to HRCT [155], and in the last one, an HRCT was done only in selected patients with apparent indications for the test (irrespective whether”
MethodAn ex vivo model of severe asthma using reconstituted human bronchial epithelium
Gras, D., BOURDIN, A. A., Vachier, I., de Senneville, L., Bonnans, C., & Chanez, P. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.073 · Cited by 94 · cited 1×
“First, the epithelium in severe asthma is reported to be thicker than in mild-moderate asthma [115], with altered proliferation, apoptosis and release of pro-inflammatory factors [116].”
BackgroundSelf-citationPedersen, S., Bateman, E. D., Bousquet, J. J., Busse, W. W., Yoxall, S., & Clark, T. J. H. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.016 · Cited by 92
Self-citationTreatment of late-onset asthma with fluconazole
Ward, G. W., Woodfolk, J. A., Hayden, M. L., Jackson, S., & Platts‐Mills, T. A. E. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70321-0 · Cited by 91
Efficacy and safety of omalizumab in an Asian population with moderate‐to‐severe persistent asthma
Ohta, K., Miyamoto, T., Amagasaki, T., Yamamoto, M., & on behalf of the 1304 Study Group (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01633.x · Cited by 90 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodInflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma
Macedo, P., Hew, M. J., Torregó, A., Jouneau, S., Oates, T. M., Durham, A. L., & Chung, K. F. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03319.x · Cited by 84 · cited 3×
“Molecular phenotyping approaches are also emerging with data from severe asthmatic children suggesting Th1 skewing compared to those with moderate asthma, while a recent transcriptome analysis of peripheral blood cells suggested differential activation of CD8+ T-cells in severe asthma as compared to CD4+ T-cells [53,…”
BackgroundResultSelf-citationImpact of Race on Asthma Treatment Failures in the Asthma Clinical Research Network
Wechsler, M. E., Castro, M., Lehman, E., Chinchilli, V. M., Sutherland, E. R., Denlinger, L., Lazarus, S. C., Peters, S. P., & Israel, E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0514oc · Cited by 83
Self-citationAlsamri, M. T., Benedetti, A., Préfontaine, D., Olivenstein, R., Lemière, C., Nair, P. K., Martin, J. G., & Hamid, Q. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.005 · Cited by 81 · cited 2×
“The role of sputum neutrophilic inflammation in guiding therapy is generally less studied, with considerable day-to-day variability in patients with severe asthma [62].”
BackgroundSelf-citationAnti-IgE for chronic asthma in adults and children (Review)
Walker, S. L., Monteil, M., Phelan, K. J., Lasserson, T., & Walters, E. H. (2004) · eCite Digital Repository (University of Tasmania) · Cited by 80
Chang, P., Bhavsar, P. K., Michaeloudes, C., Khorasani, N. M., & Chung, K. F. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.017 · Cited by 79
Self-citationFluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children
Stern, G., de Jongste, J. C., van der Valk, R. J. P., Baraldi, E., Carraro, S., Thamrin, C., & Frey, U. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.010 · Cited by 79 · cited 21×
“Daclizumab, a humanised IgG1 monoclonal antibody against the IL-2 receptor-a chain of activated lymphocytes improved FEV1 and asthma control in moderate-to-severe asthmatic adults inadequately controlled on ICS [162].”
BackgroundInfluentialSelf-citationAuranofin in the treatment of steroid dependent asthma: a double blind study.
Nierop, G., Gijzel, W. P., Bel, E. H., Zwinderman, A. H., & Dijkman, J. H. (1992) · Thorax · doi:10.1136/thx.47.5.349 · Cited by 77 · cited 1×
“considered to improve CS insensitivity, their efficacy is uncertain, and they are associated with significant side-effects [204-208].”
BackgroundSelf-citationSalmun, L. M., Barlan, I. B., Wolf, H. M., Eibl, M. M., Twarog, F. J., Geha, R. S., & Schneider, L. C. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70424-0 · Cited by 76
Low-Dose Methotrexate Spares Steroid Usage in Steroid-Dependent Asthmatic Patients
Marin, M. G. (1997) · CHEST Journal · doi:10.1378/chest.112.1.29 · Cited by 76 · cited 1×
“We found two systematic reviews [204, 291] published in 1998 and one non-systematic review with meta-analysis published in 1997 [292] that addressed this question.”
BackgroundPharmacological strategies for self-management of asthma exacerbations: Table 1—
Reddel, H. K., & Barnes, D. J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00105305 · Cited by 76
Bronchial Dilatation in Asthma
Takemura, M., Niimi, A., Minakuchi, M., Matsumoto, H., Ueda, T., Chin, K., & Mishima, M. (2004) · CHEST Journal · doi:10.1378/chest.125.4.1352 · Cited by 75
Kishiyama, J. L., Valacer, D. J., Cunningham‐Rundles, C., Sperber, K. E., Richmond, G. W., Abramson, S. L., Glovsky, M. M., Stiehm, R. E., Stocks, J., Rosenberg, L., et al. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4714 · Cited by 74
Bhavsar, P. K., Levy, B. D., Hew, M. J., Pfeffer, M. A., Kazani, S., Israel, E., & Fan Chung, K. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-71 · Cited by 74 · cited 1×
“In this regard, severe asthma has been associated with lower levels of lipoxins, with their potential anti-inflammatory qualities, than patients with milder asthma [111-113].”
BackgroundSelf-citationPsychological factors in severe chronic asthma
Vamos, M., & Kolbe, J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00591.x · Cited by 74
Good, J. T., Kolakowski, C. A., Groshong, S. D., Murphy, J. R., & Martin, R. J. (2011) · CHEST Journal · doi:10.1378/chest.11-0741 · Cited by 73
High-Dose Intramuscular Triamcinolone in Severe, Chronic, Life-Threatening Asthma
Ogirala, R. G., Aldrich, T. K., Prezant, D. J., Sinnett, M. J., Enden, J. B., & Williams, M. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240903 · Cited by 72
Secondary Outcomes of a Pilot Randomized Trial of Azithromycin Treatment for Asthma
Hahn, D. L., Plane, M. B., Mahdi, O. S., & Byrne, G. I. (2006) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0010011 · Cited by 71 · cited 1×
“We identified six additional randomized trials of macrolide antibiotics in patients with asthma [302-307] that have been published since the search for the review by Richeldi and colleagues”
BackgroundThe occupational contribution to severe exacerbation of asthma
Henneberger, P. K., Mirabelli, M. C., Kogevinas, M., Anto, J. M., Plana, E., Dahlman‐Höglund, A., Jarvis, D., Kromhout, H., Lillienberg, L., Norbäck, D., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00135109 · Cited by 71 · cited 1×
“Occupational exposures have also been associated with late onset, and often severe asthma [36].”
BackgroundNitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation
Yamamoto, M., Tochino, Y., Chibana, K., Trudeau, J. B., Holguin, F., & Wenzel, S. E. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03860.x · Cited by 70 · cited 21×
“Daclizumab, a humanised IgG1 monoclonal antibody against the IL-2 receptor-a chain of activated lymphocytes improved FEV1 and asthma control in moderate-to-severe asthmatic adults inadequately controlled on ICS [162].”
BackgroundInfluentialSelf-citationPetsky, H., Kynaston, J. A., Turner, C., Li, A., Cates, C. J., Lasserson, T. J., & Chang, A. B. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005603.pub2 · Cited by 70
Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived Cytokines
Brasier, A. R., Victor, S., Ju, H., Busse, W. W., Curran‐Everett, D., Bleecker, E., Castro, M., Chung, K. F., Gaston, B., Israel, E., et al. (2010) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2010.00204.x · Cited by 68 · cited 1×
“recent genomic and proteomic approaches have suggested increases in IL-1β in certain asthmatics, in conjunction with neutrophilia [107-109].”
BackgroundSelf-citationChu, J., Wang, R. Y., & Hill, N. S. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108138 · Cited by 68
The Impact of Bronchiectasis in Clinical Presentation of Asthma
Oğuzülgen, İ. K., Kervan, F., Öziş, T. N., & Türktaş, H. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31802fa16f · Cited by 67 · cited 1×
“selection criteria were reported in the article or not) [126, 156-159].”
BackgroundPredicting future risk of asthma exacerbations using individual conditional probabilities
Thamrin, C., Zindel, J., Nydegger, R., Reddel, H. K., Chanez, P., Wenzel, S. E., FitzPatrick, S., Watt, R. A., Suki, B., & Frey, U. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.018 · Cited by 62 · cited 1×
“The impact of these fluctuations in patients with severe asthma is less clear, although the differences in fluctuations compared to mild-moderate asthma suggest these fluctuation patterns may also be a phenotypical characteristic [140].”
BackgroundSelf-citationChung, K. F., Godard, P., Adelroth, E. C., Ayres, J., Barnes, N., Barnes, P., Bel, E. H., Burney, P., Chanez, P., Connett, G. J., et al. (1999) · Data Archiving and Networked Services (DANS) · Cited by 62
Self-citationAaron, S. D., Dales, R., & Pham, B. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90355-9 · Cited by 60
Characteristics of Bronchial Asthma with Incomplete Reversibility of Airflow Obstruction
Hudson, C., Turcotte, H., Laviolette, M., Carrier, G., & Boulet, L. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63387-x · Cited by 59
Self-citationCorticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology
Hew, M. J., & Chung, K. F. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02192.x · Cited by 56
Self-citationOral xanthines as maintenance treatment for asthma in children
Seddon, P. C., Bara, A., Lasserson, T. J., & Ducharme, F. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002885.pub2 · Cited by 56 · cited 1×
“However, no such studies have been performed in children or adults with severe asthma [239].”
BackgroundRisk Factors for Near-Fatal Asthma
Gelb, A. F., Schein, A. J., Nussbaum, E., Shinar, C. M., Aelony, Y., Aharonian, H. S., & Zamel, N. (2004) · CHEST Journal · doi:10.1016/s0012-3692(15)31289-7 · Cited by 56 · cited 1×
“after bronchodilation can have reduced lung elastic recoil accounting for a portion of their residual airflow limitation [137] Whether this is related to the reported loss of alveolar”
BackgroundCan HRCT be used as a marker of airway remodelling in children with difficult asthma?
Saglani, S., Papaioannou, G., Khoo, L., Ujita, M., Jeffery, P., Owens, C., Hansell, D., Payne, D., & Bush, A. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-46 · Cited by 55 · cited 1×
“morphometry of the airways and distal lung in adults with severe asthma, but with less is known in children [126-129].”
BackgroundSelf-citationGenome-wide association study of the age of onset of childhood asthma
Forno, E., Lasky-Su, J. A., Himes, B. E., Howrylak, J. A., Ramsey, C. D., Brehm, J. M., Klanderman, B. J., Ziniti, J. P., Melén, E., Pershagen, G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.020 · Cited by 55 · cited 1×
“Differences in asthma susceptibility genes also appear to differ by age at onset of disease, a characteristic critical to both biased and unbiased phenotyping approaches [32, 48].”
BackgroundDoeing, D. C., Mahajan, A. K., White, S. R., Naureckas, E. T., Krishnan, J. A., & Hogarth, D. K. (2012) · Journal of Asthma · doi:10.3109/02770903.2012.751997 · Cited by 53 · cited 1×
“We identified additional 2 reports of the follow-up of patients from 2 included RCTs [316, 317], and 2 case series [318, 319] but we used only the evidence from RCTs to inform this recommendation.”
MethodControlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis.
Currie, D. C., Lueck, C. J., Milburn, H. J., Harvey, C., Longbottom, J. L., Darbyshire, J. H., Nunn, A., & COLE, P. J. (1990) · Thorax · doi:10.1136/thx.45.6.447 · Cited by 53 · cited 2×
“The other study (n = 20) compared nebulized natamycin with saline inhalations in patients with ABPA [310].”
BackgroundIn vivo evaluation of the effectiveness of bronchial thermoplasty with computed tomography
Brown, R. H., Wizeman, W., Danek, C. J., & Mitzner, W. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01210.2004 · Cited by 53 · cited 1×
“5 or ACT <20 (or “not well controlled” by NAEPP or GINA guidelines over the 3 months or evaluation [20, 22])”
BackgroundChlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis
Pasternack, R., Huhtala, H., & Karjalainen, J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.030 · Cited by 51 · cited 1×
“fixed airflow limitation has been associated with positive serology for intracellular pathogens, such as Chlamydia pneumoniae [34, 91, 92].”
BackgroundBoulet, L., Turcotte, H., Hudon, C., Carrier, G., & Maltais, F. (1998) · Canadian Respiratory Journal · doi:10.1155/1998/780739 · Cited by 50 · cited 2×
“smokers [167].”
BackgroundSelf-citationMethotrexate Treatment of Severe Asthma in Children
Guss, S., & Portnoy, J. M. (1992) · PEDIATRICS · doi:10.1542/peds.89.4.635 · Cited by 50 · cited 1×
“(3–16 years) with steroid dependent asthma treated with methotrexate [295-297].”
BackgroundBreath Formate Is a Marker of Airway S-Nitrosothiol Depletion in Severe Asthma
Greenwald, R., Fitzpatrick, A. M., Gaston, B. M., Marozkina, N. V., ERZURUM, S. C., & Teague, W. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011919 · Cited by 49 · cited 1×
“dismutase and s-nitrosothiol depletion [105, 106].”
Self-citationFeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management
Verini, M., Consilvio, N. P., Pillo, S. D., Cingolani, A., Spagnuolo, C., Rapino, D., Scaparrotta, A., & Chiarelli, F. (2010) · Journal of Allergy · doi:10.1155/2010/691425 · Cited by 49 · cited 4×
“Four studies explicitly included children [47, 257-259], one included adolescents [260], and three studies enrolled”
BackgroundMethodResultInfluentialAnticholinergic therapy for acute asthma in children
Teoh, L., Cates, C. J., Hurwitz, M., Acworth, J., Asperen, P. V., & Chang, A. B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003797.pub2 · Cited by 48
Clinical profile of diseases causing chronic airflow limitation in a tertiary care centre in India.
Gothi, D., Shah, D. V., & Joshi, J. (2007) · PubMed · Cited by 47
Sales, J., Fıvush, R., & Teague, G. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm068 · Cited by 47 · cited 1×
“and poor coping skills may be associated with reduced asthma-related quality of life[179].”
BackgroundImpact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
Niebauer, K., Dewilde, S., Fox-Rushby, J. A., & Revicki, D. A. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61242-2 · Cited by 46
Omalizumab for the treatment of severe persistent allergic asthma
Jones, J., Shepherd, J., Hartwell, D., Harris, P., Cooper, K., Takeda, A., & Davidson, P. (2009) · Health Technology Assessment · doi:10.3310/hta13suppl2-05 · Cited by 46
High-resolution computed tomography findings in elderly patients with asthma
Yılmaz, S., Ekici, A., Ekici, M. S., & Keleş, H. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.03.004 · Cited by 44 · cited 2×
“Finally, Yilmaz and colleagues reported a case series of 68 elderly patients with asthma that was unlikely to be severe (FEV1 among “early onset” asthma patients was 77% and among “late onset” – 100%) [164].”
BackgroundChakir, J., Hamid, Q. A., Bossé, M., Boulet, L., & Laviolette, M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.0954-7894.2002.01323.x · Cited by 42 · cited 1×
“The mechanisms behind these diverse inflammatory profiles are likely complex, varied, and related to CS sensitivity [65, 66].”
BackgroundSelf-citationNontuberculous Mycobacterial Infection as a Cause of Difficult-to-Control Asthma
Fritscher, L. G., Marras, T. K., Bradi, A. C., Fritscher, C. C., Balter, M. S., & Chapman, K. R. (2010) · CHEST Journal · doi:10.1378/chest.10-0186 · Cited by 42
Thamrin, C., Nydegger, R., Stern, G., Chanez, P., Wenzel, S. E., Watt, R. A., FitzPatrick, S., Taylor, D. R., & Frey, U. (2011) · Thorax · doi:10.1136/thx.2010.156489 · Cited by 41 · cited 1×
“Day-to- day variations in lung function are also less variable in severe asthmatics[135].”
BackgroundSelf-citationSevere Asthma With Fungal Sensitization in a Child: Response to Itraconazole Therapy
Vicencio, A. G., Muzumdar, H., Tsirilakis, K., Kessel, A., Nandalike, K., & Goldman, D. L. (2010) · Pediatrics · doi:10.1542/peds.2009-2443 · Cited by 40 · cited 1×
“Sensitization to fungi such as aspergillus has also been associated with severe asthma development in adults [44, 45]”
BackgroundBronchial thermoplasty: a novel technique in the treatment of severe asthma
Castro, M., Musani, A. I., Mayse, M. L., & Shargill, N. S. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810367505 · Cited by 39 · cited 2×
“All included the same 3 randomized trials: a study in patients with asthma of variable severity [20], and 2 studies specifically including patients with severe asthma – one comparing thermoplasty with usual care [315] and one with a sham procedure [313].”
BackgroundSelf-citationComet, R., Domingo, C., Larrosa, M., Morón, A., Rué, M., Amengual, M. J., & Marín, A. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.07.003 · Cited by 37
Powell, H. A., Murphy, V. E., Taylor, D. R., Hensley, M. J., McCaffery, K. J., Giles, W. B., Clifton, V. L., & Gibson, P. G. (2012) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000417609.87789.d8 · Cited by 37
Self-citationNaqvi, M., Tcheurekdjian, H., DeBoard, J. A., Williams, L. K., Navarro, D., Castro, R. A., Rodríguez‐Santana, J., Chapela, R., Watson, H. G., Meade, K. E., et al. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60055-5 · Cited by 30 · cited 1×
“Thus, individuals of African racial background appear to have less short-acting bronchodilator responsiveness to SABA even after inhaled corticosteroid therapy compared to Mexican Americans and Puerto Ricans [230].”
BackgroundSubcutaneous terbutaline and control of brittle asthma or appreciable morning dipping.
Ayres, J. G., Fish, D. R., Wheeler, D. C., Wiggins, J., Cochrane, G. M., & Skinner, C. (1984) · BMJ · doi:10.1136/bmj.288.6432.1715 · Cited by 29 · cited 1×
“Page 41 of 112 repeated or continuous inhaled (nebulized or aerosol-administered) β-agonist has not been confirmed [224].”
BackgroundGelb, A. F., Taylor, C. F., Epstein, J. D., Shinar, C. M., Gutierrez, C., & Zamel, N. (2004) · CHEST Journal · doi:10.1378/chest.126.4.1138 · Cited by 28
Investigação de fatores associados à asma de difícil controle
de Araujo, A. C. S., Ferraz, É., Borges, M. D. C., Filho, J. T., & Vianna, É. O. (2007) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132007000500003 · Cited by 27 · cited 1×
“in a way that precluded conclusions [134, 150-152].”
ResultTurchiarelli, V., Schinkel, J., Molenkamp, R., Barbaro, M. P. F., Carpagnano, G. E., Spanevello, A., Lutter, R., Bel, E. H., & Sterk, P. J. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02600.x · Cited by 23 · cited 1×
“relation to asthma severity has rarely been addressed [88-90].”
BackgroundSelf-citationWu, Q., Xing, Y., Zhou, X., & Wang, D. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900102 · Cited by 20 · cited 1×
“We found one systematic review [312] and 2 narrative reviews [313, 314] of bronchial thermoplasty in patients with asthma.”
BackgroundBronchial thermoplasty for severe asthma
Cox, G. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283410ae4 · Cited by 19 · cited 1×
“We found one systematic review [312] and 2 narrative reviews [313, 314] of bronchial thermoplasty in patients with asthma.”
BackgroundMethotrexate in the treatment of corticodependent asthmatic children.
Solé, D., Costa-Carvalho, B. T., Soares, F. J. P., Rullo, V. E. V., & Naspitz, C. K. (1996) · PubMed · Cited by 18
Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 years
Walker, S., Burch, J., McKenna, C., Wright, K. E., Griffin, S. C., & Woolacott, N. F. (2011) · Health Technology Assessment · doi:10.3310/hta15suppl1/02 · Cited by 17 · cited 2×
“The authors of a health technology assessment of omalizumab in children aged 6 to 11 estimated the most plausible ICER for the subgroup of children with severe asthma and at least 3 exacerbations in the previous year to be US$ 129,739 per QALY gained [288].”
BackgroundEffects of inhaled steroids on growth, bone metabolism and adrenal function
Allen, D. B. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.1.65 · Cited by 17
Management of β-agonist overuse: Why and how?
Taylor, D. R., & Hannah, D. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.025 · Cited by 15 · cited 1×
“Case reports suggest ‘improvement in asthma control’ upon medically-supervised reduction of βagonists in some severe adult asthma patients taking excessive β-agonists [232].”
BackgroundBeilby, J. J. (2006) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2006.08.003 · Cited by 10
High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma
Johanos, A. M. (1991) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)83002-1 · Cited by 6
[High resolution computed tomography findings in patients with asthma].
Yorgancıoğlu, A., Şakar, A., Tarhan, S., Çelik, P., & Göktan, C. (2003) · PubMed · Cited by 6
BROWN, L., PARROT, H., & Porter, E. (1963) · JAMA · doi:10.1001/jama.1963.03700170125080 · Cited by 2
Research works printed but not linked: 1
- 10.1080/j.1440-1614.1999.00591.x · doi:10.1080/j.1440-1614.1999.00591.x · Paper page
Cited by
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
“Oropharyngeal pain 15 (8) 12 (6) 7 (4)”
Self-citationPapi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33311-1 · Cited by 1,759
Self-citationOral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Self-citationBleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
Self-citationFitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
Self-citation
Metadata
- Authors
- Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., Boulet, L.-P., Brightling, C., Chanez, P., Dahlen, S.-E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jarjour, N. N., Mauad, T., Sorkness, R. L., & Teague, W. G.
- Affiliations
- Royal Brompton Hospital (GB)
- University of Pittsburgh (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Imperial College London (GB)
- University of Cape Town (ZA)
- Wake Forest University (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- University of Leicester (GB)
- Aix-Marseille Université (FR)
- Karolinska Institutet (SE)
- University of Basel (CH)
- John Hunter Hospital (AU)
- McGill University (CA)
- University of Wisconsin System (US)
- University of Virginia (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2013-12-12
- Volume
- 43
- Issue
- 2
- Pages
- 343-373
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2098276532
- Cited by
- 3,926
- References
- 321
- Citations by year
- 2026: 204 · 2025: 296 · 2024: 347 · 2023: 335 · 2022: 370 · 2021: 404 · 2020: 425 · 2019: 397 · 2018: 339 · 2017: 315 · 2016: 224 · 2015: 174 · 2014: 85 · 2013: 2
- FWCI
- 112.27
- Type
- journal article
- Language
- en
- Update notices
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10192, NF-SI-0512-10018, NF-SI-0509-10080)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- severe asthma, therapy-resistant asthma, asthma phenotypes, eosinophilic asthma, exhaled nitric oxide, anti-IgE, methotrexate, macrolide antibiotics, antifungal agents, bronchial thermoplasty, high-dose inhaled corticosteroids, systemic corticosteroids, asthma phenotyping, biomarkers, children and adults
- MeSH terms
- Adrenal Cortex Hormones, Asthma, Clinical Trials as Topic, Humans, Immunoglobulin E, Immune System, International Cooperation, Phenotype, Risk Factors, Pulmonary Medicine, Biomarkers, Comorbidity, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.